Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts

Leukemia

Volumn 15, Issue 12, 2001, Pages 1923-1931

  Birkenkamp, K U ^a   Geugien, M ^a   Lemmink, H H ^a   Kruijer, W ^a   Vellenga, E ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

AML; Constitutive activation; Flt3; STAT5

Indexed keywords

CELL PROTEIN; GROWTH FACTOR; PROTEIN BCL XL; PROTEIN TYROSINE KINASE INHIBITOR; STAT5 PROTEIN; TYROSINE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; AUTOPHOSPHORYLATION; BLAST CELL; CLINICAL ARTICLE; DATA ANALYSIS; GENE DUPLICATION; GENE MUTATION; HUMAN; MODULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0035203382     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402317     Document Type: Article

References (46)

1. The biology of acute myeloblastic leukemia
2. Oncogenic transcription factors in the human acute leukemias
3. Translocations, master genes, and differences between the origins of acute and chronic leukemias
4. Chromosomal translocations in human cancer
5. Chromosome aberrations and cancer
6. The Jak-Stat pathway in normal and perturbed hematopoiesis
7. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs
8. Critical cytoplasmic domains of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation
9. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane proximal region
10. STATs and gene regulation
11. Deletion of the carboxy-terminal transactivation domain of MGF-STAT5 results in sustained DNA-binding and a dominant negative phenotype
12. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation
13. Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway
14. Fetal anemia and apoptosis of red-cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-X(L) induction
15. STAT5-dependent cyclinD1 and Bcl-xL expression in Bcr-abl-transformed cells
16. The Bcl-2 protein family: Arbiters of cell survival
17. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts
18. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients
19. Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6
20. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells
21. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling
22. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family
23. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells
24. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations
25. Receptor tyrosine kinases
26. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors
27. Effects of human FLT3 ligand on myeloid leukemia cell growth: Heterogeneity in response and synergy with other hematopoietic growth factors
28. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells
29. Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling
30. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on large series of patients and cell lines
31. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene
32. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product
33. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
34. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways
35. Proposed revised criteria for the classification of acute myeloid leukemia
36. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia
37. In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells
38. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
39. Selective platelet-derived growth factor receptor kinase blockers reverse cis-transformation
40. Expression of the c-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance
41. A single amino acid in the DNA binding regions of STAT5a and STAT5b confers distinct DNA binding specificities
42. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
43. Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells
44. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
45. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes
46. Bcr/Abl activates transcription of the Bcl-X gene through STAT5